| Patents for C07H 19 - Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro derivatives thereof (20,008) |
|---|
| 02/01/2001 | WO2001006986A2 5-(e)-bromovinyl uracil analogues and related pyrimidine nucleosides as anti-viral agents and methods of use |
| 02/01/2001 | WO2000058405A3 Squaraine dyes |
| 02/01/2001 | WO2000050432A3 Synthesis of labelled oligonucleotides on solid-supports |
| 02/01/2001 | WO2000008041A9 Structural analogs of amine bases and nucleosides |
| 02/01/2001 | CA2379834A1 Enzyme catalyzed anti-infective therapeutic agents |
| 01/31/2001 | EP1072607A2 Purine L-nucleosides, analogs and uses therof |
| 01/31/2001 | EP1071812A1 A method, reagent solution and kits for dna sequencing |
| 01/31/2001 | EP1071693A1 Novel crystalline forms of an antiviral benzimidazole compound |
| 01/31/2001 | CN1282378A Analyte assay using particulate labels |
| 01/31/2001 | CN1282218A Compositions and method for treatment of primary and metastatic neoplastic diseases using arsenic compounds |
| 01/30/2001 | US6180766 Nucleosides and oligonucleotides containing boron clusters |
| 01/30/2001 | US6180615 Propargyl phenyl ether A2A receptor agonists |
| 01/30/2001 | US6180403 Antisense inhibition of tumor necrosis factor alpha converting enzyme (TACE) expression |
| 01/30/2001 | US6180353 Nucleotide sequences associated with suppression of transcription binding protein associated with apoptosis; for the treatment and prevention defects associated with apoptosis |
| 01/25/2001 | WO2001005837A1 Method for assaying compounds affecting smooth muscle contractile state |
| 01/25/2001 | WO2001005801A1 Novel nucleic acid base pair |
| 01/25/2001 | WO2001005773A1 Conjugates of sodium channel blockers and methods of using the same |
| 01/25/2001 | CA2378181A1 Conjugates of sodium channel blockers and methods of using the same |
| 01/24/2001 | EP1070079A2 Method for the production of pentopyranosyl nucleosides |
| 01/24/2001 | EP1070078A2 Form vi 5,6-dichloro-2-(isopropylamino)-1-beta-l-ribofuranosyl)-1h-benzimidazole |
| 01/24/2001 | EP1070076A1 Chiral separations of pyrimidines |
| 01/24/2001 | EP1070068A1 Granulatimide derivatives for use in cancer treatment |
| 01/24/2001 | EP1069903A1 Novel nucleoside analogs and uses in treating disease |
| 01/23/2001 | US6177557 Nucleotide sequences which bind preferential proteins; for use as coagulants and in prevention of neovascularization |
| 01/23/2001 | US6177409 Method for the site specific synthesis of novel 3-hydroxypyridin-4(1H)ons derivatives from aminomonosaccharides or aminoitols, products obtained by this method and their applications |
| 01/23/2001 | CA2017369C Modified phosphoramidite process for the production or modified nucleic acids |
| 01/18/2001 | WO2001004134A2 Novel esters derived from nucleosides, preparation methods and pharmaceutical compositions containing them |
| 01/18/2001 | WO2000062803A3 ppGpp AND pppGpp AS IMMUNOMODULATORY AGENTS |
| 01/18/2001 | WO1999064049A9 Novel antibacterial agents |
| 01/18/2001 | CA2374411A1 Novel esters derived from nucleosides, preparation methods and pharmaceutical compositions containing them |
| 01/17/2001 | EP1068346A1 Nucleotide activated disaccharides and oligosaccharides and method for the production thereof |
| 01/17/2001 | EP1068345A1 Nucleotide activated disaccharides and oligosaccharides and a method for the production thereof |
| 01/17/2001 | EP1068215A1 Azt derivatives exhibiting spermicidal and anti-viral activity |
| 01/17/2001 | EP0581959B1 Use of macrolide compounds for eye diseases |
| 01/17/2001 | CN1060781C Phosphonomonoester nucleic acids, process for treir preparation, and their use |
| 01/16/2001 | US6175005 Single stage reaction for blocking hydroxyl groups on cyclic ether by reacting with defined difunctional silicon compound, with defined monofunctional silicon group, then with hydrofluoric acid in the presence of a nitrogen base |
| 01/16/2001 | US6175004 Process for the synthesis of oligonucleotides incorporating 2-aminoadenosine |
| 01/16/2001 | US6175001 Derivatized at c5 to contain functional group that mimics the property of naturally occurring amino acid; for use in polymerase chain reactions |
| 01/16/2001 | US6174998 C-nucleoside derivatives and their use in the detection of nucleic acids |
| 01/16/2001 | US6174873 Oral administration of adenosine analogs |
| 01/11/2001 | WO2001002419A1 C3'-methylene hydrogen phosphonate oligomers and related compounds |
| 01/11/2001 | WO2001002417A1 Nucleotide monomer containing six-membered azarsugar and antisense oligomers thereof |
| 01/11/2001 | WO2001002415A1 C3'-methylene hydrogen phosphonate monomers and related compounds |
| 01/11/2001 | WO2001002020A2 Compositions and methods for targeted enzymatic release of cell regulatory compounds |
| 01/11/2001 | WO2000066604A3 L-ribo-lna analogues |
| 01/10/2001 | EP1066266A1 Cyclin dependent kinase inhibitors |
| 01/10/2001 | CN1279687A Bi-and tri-cyclic nucleoside, nucleotide and oligonucleotide analoguse |
| 01/10/2001 | CN1279686A Inhibitors of nucleoside metabolism |
| 01/10/2001 | CN1060483C Intermediate of doramectin for antiparastic chemical and its preparing method |
| 01/09/2001 | US6172209 Aminooxy-modified oligonucleotides and methods for making same |
| 01/04/2001 | WO2001000641A1 Novel bicyclonucleoside derivatives |
| 01/04/2001 | WO2001000627A1 New indolocarbazole alkaloids from a marine actinomycete |
| 01/04/2001 | WO2000029420A9 Methods of making modified nucleosides |
| 01/03/2001 | EP1065250A1 New fluorescent cyanine labels containing a sulfamido linker arm |
| 01/03/2001 | EP1063986A1 Compounds and methods for use in treating neoplasia, cancer, hyperproliferative cell growth and chronic inflammatory diseases |
| 01/03/2001 | EP0637244B1 A strain of streptomyces avermitilis glycosylates avermectin compounds |
| 01/02/2001 | US6169170 Oligonucleotide N3′→N5′Phosphoramidate Duplexes |
| 01/02/2001 | US6169169 PNA probes for detection of Neisseria gonorrhoeae and Chlamydia trachomatis |
| 01/02/2001 | US6168778 Vascular endothelial growth factor (VEGF) Nucleic Acid Ligand Complexes |
| 12/28/2000 | WO2000078779A2 N-pyrazole a2a receptor agonists |
| 12/28/2000 | WO2000078778A2 C-pyrazole a2a receptor agonists |
| 12/28/2000 | WO2000078777A1 Propargyl phenyl ether a2a receptor agonists |
| 12/28/2000 | WO2000078776A2 Thiophene a2a receptor agonists |
| 12/28/2000 | WO2000078775A1 Novel 3'-4' bridged nucleosides and oligonucleotide analogues |
| 12/28/2000 | WO2000078774A2 Induction of pharmacological stress with adenosine receptor agonists |
| 12/28/2000 | DE19911680A1 New extracts and compounds from Ganoderma pfeifferi , useful e.g. as antibacterial and antiviral agents, preservatives, cosmetic, pharmaceutical and food additives and in fish farming, are protease inhibitors |
| 12/27/2000 | EP1062840A1 Apparatus and method for a custom soft-solid hearing aid |
| 12/27/2000 | EP1062362A1 Levo-monosaccharide in a nucleoside analog for use as an antiretroviral agent |
| 12/27/2000 | EP1061922A1 USE OF $i(N)-SUBSTITUTED-1,5-DIDEOXY-1,5-IMINO-D-GLUCITOL COMPOUNDS FOR TREATING HEPATITIS VIRUS INFECTIONS |
| 12/27/2000 | EP0716604A4 Thiol-derivatized nucleosides and oligonucleosides |
| 12/26/2000 | US6166199 Contacting purine with amino, hydrazine, hydroxylamine, thiol, semicarbazide, thiosemicarbazide, hydrazone, hydrazide, imidazole, tetrazole, triazole, pyrrolidine, piperidine, piperazine, morpholine, aldehyde, ketone, alcohol; antisense |
| 12/26/2000 | US6166197 Oligomeric compounds having pyrimidine nucleotide (S) with 2'and 5 substitutions |
| 12/26/2000 | US6166188 Nucleosides and oligonucleosides functionalized to include carbamate functionality; for the diagnosis of normal or disease states of cells, cellular components or organisms and treatment of diseases through modulation of dna, rna |
| 12/26/2000 | US6165787 Regulated transcription of targeted genes and other biological events |
| 12/26/2000 | US6165717 Method of synthesizing diverse collections of oligomers |
| 12/26/2000 | CA2183453C Antiparasitic agents |
| 12/26/2000 | CA2150671C Compositions containing acyclovir-like compounds and 2'-vinyl substituted nucleoside analogs for the treatment of viral infections |
| 12/21/2000 | WO2000077020A1 Novel compounds derived from nucleosides, preparation methods and pharmaceutical compositions containing same |
| 12/21/2000 | WO2000077019A1 Novel compounds derived from carrageenan, preparation methods and pharmaceutical compositions containing same |
| 12/21/2000 | WO2000077018A2 Purine derivatives |
| 12/20/2000 | EP1060639A1 Compliant hearing aid and method of manufacture |
| 12/20/2000 | EP1060264A1 Dideoxy dye terminators |
| 12/20/2000 | EP1060183A1 5'-deoxycytidine derivatives |
| 12/20/2000 | EP1060182A2 Novel prodrugs for phosphorus-containing compounds |
| 12/19/2000 | US6162910 Efficient process for preparing antibiotic containing nitro group by contacting antibiotic having nitroso, hydroxyamino, or amino with oxidizing agent, catalyst of cobalt(ii) acetylacetonate or manganese(ii) acetylacetonate and solvent |
| 12/14/2000 | WO2000075378A1 Fluorescence energy transfer probes with stabilized conformations |
| 12/14/2000 | WO2000075236A1 Extended rhodamine compounds useful as fluorescent labels |
| 12/14/2000 | WO2000075158A2 NOVEL 6-PHENYLPURINE 9-β-D-RIBONUCLEOSIDES WITH ANTINEOPLASTIC ACTIVITY, THEIR USE FOR PREPARING PHARMACEUTICAL COMPOSITIONS AND PHARMACEUTICAL PREPARATIONS CONTAINING SUCH COMPOUNDS |
| 12/14/2000 | WO2000075157A1 Oligonucleotide synthesis with lewis acids as activators |
| 12/14/2000 | WO2000075154A2 Protected nucleosides |
| 12/14/2000 | WO2000075142A2 Dna methyltransferase inhibitors |
| 12/14/2000 | WO2000044763A3 Compositions for treating inflammatory response |
| 12/14/2000 | CA2376016A1 Oligonucleotide synthesis with lewis acids as activators |
| 12/14/2000 | CA2373279A1 Dna methyltransferase inhibitors |
| 12/14/2000 | CA2365075A1 Extended rhodamine compounds useful as fluorescent labels |
| 12/13/2000 | EP1058687A1 Nucleosides |
| 12/13/2000 | EP1058686A1 2'-fluoronucleosides |
| 12/12/2000 | US6160109 Preparation of phosphorothioate and boranophosphate oligomers |
| 12/12/2000 | US6159952 Bronchodilator agents |
| 12/12/2000 | US6159951 2'-O-amino-containing nucleoside analogs and polynucleotides |